"[T]here was a profound lack of consensus on how to incorporate clinical nuance, patient preferences and priorities, and cost-benefit tradeoffs into provider and consumer-facing initiatives to reduce low-value care. One employee benefits executive commenting on competing risks stated, 'I think this starts to tread into some really difficult ... ethical territory.... If it's benefit's decision to say somebody in this situation doesn't get access to the service, I don't think we would ever do that.' However, a clinical professional from oncology was in favor of using competing risks in decision making and commented 'A treatment that might be considered as appropriate treatment for [one] patient ... might be considered to be a very poor choice for a patient who's got significant competing risk.' "  MORE >>